Industry: Pharmaceuticals, Biotechnology
CovX was founded in 2002 based on the research of Carlos Barbas, Ph.D. and Richard Lerner, M.D. at The Scripps Research Institute. Since its founding, CovX has made advances toward building a portfolio of product candidates. We use our proprietary technology to rapidly discover and develop long-acting biological therapies. The CovX technology unites the therapeutic attractiveness of peptides with the beneficial properties of antibodies, resulting in a new biopharmaceutical called a CovX-Body. The highly flexible nature of our technology enables us to identify high-value biological targets, efficiently create CovX-Bodies, and expeditiously move candidates to pre-clinical development and clinical ( www.covx.com )
CovX
9381 Judicial Drive Suite 200
San Diego, California 92121
USA
Tel: (858) 964-2000
Fax: (858) 964-2090